正在进行以添加第三种药物的研究，即静脉注射的前列腺素类花青素。
Studies are underway investigating the addition of a third agent, the intravenous prostanoid epoprostenol.
目的：评价清热利湿类中药复方治疗慢性前列腺炎的疗效和安全性。
Objective: To evaluate the efficacy and safety of the Qingrelishi-category Chinese medicine (for dispelling heat and resolving dampness) in the treatment of chronic prostatitis.
对于病人来说，疾病还没有得到良好的控制，目前正在进行有关第三种药物即静脉前列腺素类依前列醇的研究。
For patients whose disease is still not well-controlled, studies are underway investigating the addition of a third agent, the intravenous prostanoid epoprostenol.
应用推荐